Genome-wide microarray analyses show reduced levels of PGC-1α mRNA in the hippocampi of human post-mortem AD brains compared to healthy controls, and that PGC-1α protein levels are negatively associated with neurotic plaques and amyloid-β1–42 content [96]. This evidence concerns the gene PPARGC1A and Alzheimer disease.